文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

推进空间驱避剂用于疟疾控制:在乌干达北部实际使用条件下空间驱避剂有效性与成本效果的一项整群随机对照试验研究方案

Advancing spatial repellents for malaria control: effectiveness and cost-effectiveness of a spatial repellent under operational use in Northern Uganda-study protocol for a cluster randomized controlled trial.
PubMed 文献 · Trials · 2024-08-22

该研究方案拟在乌干达北部通过3个儿童队列,比较经参考渠道、代金券渠道和乡村卫生团队渠道分发空间驱避剂对疟疾感染的保护效果,以评估其在高传播、全年流行地区实际使用中的有效性,为政策制定提供依据。

要点

  • 研究在乌干达北部高传播、全年疟疾流行区开展,比较三种分发渠道下空间驱避剂对儿童疟疾感染的保护效果。
  • 每个队列每月随访两次,第一次访视采集血样做疟疾快速诊断检测,第二次访视仅在近期有发热史时采血。
  • 研究旨在填补空间驱避剂在人道援助和应急响应环境中减少疟疾的知识空白。

核心结论

  • 该研究将评估空间驱避剂在人道援助和应急响应环境中是否有效减少人类疟疾,为政策制定者是否推荐其作为进一步减少疟疾传播的手段提供依据。

研究设计与样本

  • 整群随机对照试验,在乌干达北部招募儿童进入3个独立队列,分别评估经参考渠道(研究人员分发)、代金券渠道和乡村卫生团队渠道分发空间驱避剂的效果。
  • 每个队列每月随访两次(约每15天一次),第一次访视采集血样行疟疾快速诊断检测,第二次访视仅在参与者近期有发热史时采血。
  • 各队列疟疾发病率将与参考队列比较,以确定在高传播、全年疟疾流行区使用空间驱避剂的益处。
  • 试验注册号ClinicalTrials.gov NCT06122142,注册日期2023年11月8日。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spatial repellents (SRs) have been widely used for the prevention of mosquito bites, and preliminary findings suggest efficacy against both malaria (1) and Aedes-borne viruses (2) but their effectiveness in reducing mosquito-borne diseases under operational use has never been evaluated. SRs have the potential of being critical tools in the prevention of mosquito-borne diseases in contexts where typical vector control strategies, such as insecticide-treated nets (ITNs) and indoor residual spraying, are inaccessible or underutilized such as among displaced persons or in emergency relief settings. METHODS: Children will be enrolled in 3 separate cohorts to establish the effectiveness of SRs in reducing malaria infection in different distribution channels. One cohort will estimate the direct effect of the SR distributed through a reference channel (study personnel distribution). The two remaining cohorts will estimate the protection of the SR distributed through a voucher channel and the Village Health Team channel. Cohorts will be followed twice a month (approximately every 15 days): during the first scheduled household visit in the month, a blood sample will be taken for malaria rapid diagnostic test (Monthly Visit #1); and, during the second scheduled household visit, a blood sample will only be taken if the participant has a recent history of fever (Monthly Visit #2). The incidence of malaria in each cohort will be estimated and compared to the reference cohort to determine the benefit of using a SR in an area with high, year-round transmission of malaria. DISCUSSION: This study will address the knowledge gap of whether or not SRs are effective in reducing human malaria disease in humanitarian assistance and emergency response settings in sub-Saharan Africa where underlying transmission rates are historically high and ITNs may or may not be widely deployed. This research will inform policy makers on whether to recommend SRs as a means to further reduce malaria transmission for such operational programs. TRIAL REGISTRATION: ClinicalTrials.gov NCT06122142. Registered on November 8, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nakyaze E, Van Hulle S, Hembling J, et al. Advancing spatial repellents for malaria control: effectiveness and cost-effectiveness of a spatial repellent under operational use in Northern Uganda-study protocol for a cluster randomized controlled trial. Trials. 2024. PMID: 39175062. doi:10.1186/s13063-024-08378-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。